Clinical Trial Update: Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating the effect of fludrocortisone on norepinephrine-mean arterial pressure dose-response in septic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Fludrocortisone (Fludrocortisone)

Snippet

Sponsor: Rennes University Hospital | Conditions: Septic Shock | Phase 3 | Status: WITHDRAWN